In this review, the efficacy and related mechanisms of SFN in the treatment of liver diseases, including fatty liver disease, hepatic insulin resistance, xenobiotic-induced liver injury, hepatic ischemia-reperfusion injury, and hepatocellular carcinoma (HCC), were summarized. This evidence concerns the gene INS and fatty liver disease.